Supply Chain Council of European Union | Scceu.org
Distribution

OptiBiotix Health PLC seals distribution deal for LPLDL in the USA and Canada

Market exclusivity is linked to a six month time to first order and to sales volumes

() has signed a distributor agreement with Advanced NutriSolutions Inc./Select Ingredient covering the United States and Canada.

Under the terms of the agreement, Advanced NutriSolutions Inc./Select Ingredient will supply OptiBiotix’s cholesterol and blood pressure-reducing probiotic strain Lactobacillus plantarum LPLDL, under an exclusive licence, to customers in the United States and Canada for inclusion into dietary supplements formulation.

Advanced NutriSolutions Inc./Select Ingredient supplies nutritional ingredients, contract manufacturing services, and finished products to the nutritional supplement industry.

Steve Prescott, the chief executive of ProBiotix, a wholly-owned subsidiary of OptiBiotix, said the agreement would expand LPLDL‘s reach and service level in the United States and Canada.

“Advanced NutriSolutions Inc./Select Ingredient was chosen as our partner in this important region because of their technical expertise in functional ingredients including probiotics, their industry reputation, and their manufacturing capabilities which allows them not only to sell LPLDL as an ingredient but to also create custom formulation and products for customers,” Prescott said.

Related posts

UNITED NATURAL FOODS NAMES 360PR+ AGENCY OF RECORD

scceu

Canal Plus to land beIN’s Ligue 1 rights in exclusive distribution deal

scceu

Global Healthcare Distribution Market Size to Increase to 7.7% by 2026

scceu